XML 36 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements, Recurring and Nonrecurring
Liabilities Measured at Fair Value on a Recurring Basis as of March 31, 2019
 
Quoted Prices in
Active  Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable  Inputs
(Level 2)
 
Significant
Unobservable  Inputs
(Level 3)
 
Balance as of
March 31, 2019
 
(in thousands, unaudited)
Liabilities
 
 
 
 
 
 
 
Contingent obligation due selling unitholders of Cogent
$

 
$
18,868

 
$

 
$
18,868

Total
$

 
$
18,868

 
$

 
$
18,868


Liabilities Measured at Fair Value on a Recurring Basis as of December 31, 2018
 
Quoted Prices in
Active  Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable  Inputs
(Level 2)
 
Significant
Unobservable  Inputs
(Level 3)
 
Balance as of December 31, 2018
 
(in thousands)
Liabilities
 
 
 
 
 
 
 
Contingent obligation due selling unitholders of Cogent
$

 
$
18,293

 
$

 
$
18,293

Total
$

 
$
18,293

 
$

 
$
18,293

Assets Measured at Fair Value on a Recurring Basis as of March 31, 2019
 
Quoted Prices in
Active  Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable  Inputs
(Level 2)
 
Significant
Unobservable  Inputs
(Level 3)
 
Balance as of
March 31, 2019
 
(in thousands, unaudited)
Assets
 
 
 
 
 
 
 
Cash equivalents
$
25,052

 
$

 
$

 
$
25,052

Total
$
25,052

 
$

 
$

 
$
25,052

Assets Measured at Fair Value on a Recurring Basis as of December 31, 2018
 
Quoted Prices in
Active  Markets for
Identical Assets
(Level 1)
 
Significant Other
Observable  Inputs
(Level 2)
 
Significant
Unobservable  Inputs
(Level 3)
 
Balance as of December 31, 2018
 
(in thousands)
Assets
 
 
 
 
 
 
 
Cash equivalents
$
72,193

 
$

 
$

 
$
72,193

Total
$
72,193

 
$

 
$

 
$
72,193

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

Changes in Level 3 liabilities measured at fair value on a recurring basis for the three month period ended March 31, 2018 are as follows:
 
Opening Balance as of January 1, 2018
 
Total realized and unrealized gains (losses) included in Net Income
 
Unrealized gains (losses) included in Other Comprehen-sive Income
 
Purchases
 
Issues
 
Sales
 
Settlements
 
Closing Balance as of March 31, 2018
 
Unrealized gains (losses) for Level 3 liabilities outstanding at March 31, 2018
 
(in thousands, unaudited)
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contingent obligation due to selling unitholders of Cogent
$
13,763

 
$
(910
)
 
$

 
$

 
$

 
$

 
$

 
$
14,673

 
$
(910
)
Total
$
13,763

 
$
(910
)
 
$

 
$

 
$

 
$

 
$

 
$
14,673

 
$
(910
)